What gastroenterologists should know during COVID-19 Pandemic!
Pak J Med Sci
; 36(COVID19-S4): S124-S125, 2020 May.
Article
in English
| MEDLINE | ID: covidwho-1726821
ABSTRACT
The WHO has declared a Pandemic due to Novel Corona virus-19 (COVID-19). Patients usually have respiratory symptoms but gastrointestinal and hepatic dysfunction are not uncommon presentations and can lead to a delay in diagnosis and management. Virus shedding can continue even after the nasopharyngeal swab gets negative and could lead to faecal-oral transmission. The effects of COVID-19 on patients with decompensated liver disease is still not clear. Managing immunosuppressive drugs in liver transplant and inflammatory bowel disease is a major challenge without clear guidelines. Only emergency endoscopy is to be done with personal protection equipment. Chloroquine and Hydroxychloroquine has shown some beneficial effects and is being used off-label. Without effective treatment, it is imperative to take precautionary measures.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Pak J Med Sci
Year:
2020
Document Type:
Article
Affiliation country:
Pjms.36.COVID19-S4.2651
Similar
MEDLINE
...
LILACS
LIS